Jim Plante, the CEO of IMX, in a recent interview with John Lothian News, discussed the next steps for the healthcare-focused futures exchange after receiving approval from the CFTC. IMX’s target launch is in the second quarter of 2024, and Plante said the next challenge is the ongoing process of onboarding futures commission merchants to the exchange. IMX is also working on finalizing its initial product offerings, which will undergo regulatory approval. IMX plans to make significant announcements regarding index licensing partnerships related to healthcare futures contracts. Plante emphasized that the healthcare industry, which constitutes nearly 20% of the economy, involves natural market players on both sides, including healthcare service providers, pharmaceutical companies, and health insurance providers, necessary components for a healthy futures market.